Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosela for prevention of chemotherapy-induced bone marrow suppression in advanced gastric cancer
ChiCTR2300073043Phase 4Recruiting
- Sponsor
- Xijing Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of trilaciclib in gastric adenocarcinoma (2 arms), sponsored by Xijing Hospital. Primary endpoint: neutrophil count. Started Jun 2023; status: recruiting.
02
Drugs
trilaciclib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR2300073043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073043.